知镜 Cognispect · 医学文献与研究工作台

Racial/Ethnic Disparities in Risk of Second Primary Malignancies among Diffuse Large B-Cell Lymphoma Survivors.

Gole Advani P, Yu H, Catalfamo K, Torka P.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026-10-01 · PMID 42565782

文献摘要

Background Previous studies have shown an increased risk of second primary malignancies (SPM) among diffuse large B-cell lymphoma (DLBCL) survivors; however, this has not been comprehensively examined by race/ethnicity. Methods From 17 US population-based Surveillance, Epidemiology, and End Results (SEER) program cancer registry areas, we identified 68,358 ≥ 12-month DLBCL survivors diagnosed between 2000 and 2022. Standardized incidence ratios (SIR) and accompanying 95% confidence intervals (CI) quantified SPM risk that occurred ≥12-month after DLBCL by race/ethnicity. Results Overall, we observed 6,261 SPMs after DLBCL representing a 1.2-fold significantly increased risk (95% CI, 1.16-1.22) compared with the general SEER population and an excess of 23 cases/10,000 person-years. SPM risk varied significantly by race/ethnicity, with Asian/Pacific Islanders and Hispanics presenting higher overall risk compared with the White or Black patients (Pheterogeneity Conclusions We observed substantial disparities in SPM risk by race/ethnicity, with patients belonging to minority groups experiencing higher risks. Impact SPMs have emerged as an important challenge for DLBCL survivors; therefore, further research to understand drivers of this observed racial/ethnic heterogeneity is warranted.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。